About 71,400 results
https://finance.yahoo.com/q?s=arnaArena Pharmaceuticals Inc (NASDAQ:ARNA): Is Healthcare Attractive Relative
To NasdaqGS Peers? Arena Pharmaceuticals Inc (NASDAQ:ARNA), a $1.47B
small-cap, operates in the healthcare industry, which has experienced tailwinds
from issues such as higher demand driven by an aging population and the ...
... sector and description for Arena Pharmaceuticals. A clinical-stage
Rating: 2 - 836 votes
biopharmaceutical company focused on discovering, developing and
commercializing oral drugs in four major therapeutic areas: cardiovascular,
central nervous system, inflammatory and metabolic diseases. Exchange:
NASDAQ; Sector: Healthcare ...
https://stocktwits.com/symbol/ARNA©2018 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX
Real-Time Price. Arena Pharmaceuticals, Inc. ARNA39.97. 0.88 (2.15%).
UPDATED Feb 23, 2018 10:44 PM EST. 6,988 Watchers. Watch. Filter by: Real-
Time. About · Team · Help · Blog · House Rules · Best Practices · Developers ·
https://www.marketwatch.com/investing/stock/arnaDow, 25,309.99, 347.51, 1.39%. S&P 500, 2,747.30, 43.34, 1.60%. Nasdaq,
7,337.39, 127.31, 1.77%. GlobalDow, 3,152.06, 32.72, 1.05%. Gold, 1,330.50, -
2.20, -0.17%. Oil, 63.57, 0.80, 1.27% ...
https://www.thestreet.com/quote/ARNA.htmlView detailed financial information, real-time news, videos, quotes and analysis
on Arena Pharmaceuticals Inc. (NASDAQ:ARNA). Explore commentary on Arena
Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about
https://seekingalpha.com/.../4137067-arena-pharmaceuticals-binary-events- horizonJan 11, 2018 ... Arena Pharmaceuticals (ARNA) is setting itself up for an interesting start to 2018.
The company presented at the 36th Annual JP Morgan Healthcare Conference
on January 10th and outlined its initiatives for the year which include some
compelling binary events. These types of events can provide a great ...
https://www.benzinga.com/.../arena-pharma-upgraded-ahead-of-clinical-data- releaseJan 3, 2018 ... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) received an upgrade from Wall
Street on Wednesday as it awaits Phase 2 data for the S1P modulator etrasimod
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. Wikipedia
Headquarters: San Diego, CA
CEO: Amit D. Munshi
CFO: Kevin R. Lind
Chief medical officer: Preston Klassen (M.h.s., Research, Development)